Literature DB >> 23643283

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.

Tomas G Neilan1, Otavio R Coelho-Filho, Ravi V Shah, Siddique A Abbasi, Bobak Heydari, Eri Watanabe, Yucheng Chen, Damien Mandry, Francois Pierre-Mongeon, Ron Blankstein, Raymond Y Kwong, Michael Jerosch-Herold.   

Abstract

OBJECTIVES: This study aimed to test the characteristics of the myocardial extracellular volume fraction (ECV) derived from pre- and post-contrast T1 measurements among healthy volunteers.
BACKGROUND: Cardiac magnetic resonance (CMR) T1 measurements of myocardium and blood before and after contrast allow quantification of the ECV, a tissue parameter that has been shown to change in proportion to the connective tissue fraction.
METHODS: Healthy volunteers underwent standard CMR imaging with administration of gadolinium. T1 measurements were performed with a Look-Locker sequence followed by gradient-echo acquisition. We tested the segmental, interslice, inter-, intra-, and test-retest characteristics of the ECV, as well as the association of the ECV with other variables. Juvenile and aged mice underwent a similar protocol, and cardiac sections were harvested for measurement of fibrosis.
RESULTS: In healthy volunteers (N = 32, 56% female; age 21 to 72 years), the ECV averaged 0.28 ± 0.03 (range 0.23 to 0.33). The intraclass coefficients for the intraobserver, interobserver, and test-retest absolute agreements of the ECV were 0.94 (95% confidence interval: 0.84 to 0.98), 0.93 (95% confidence interval: 0.80 to 0.98), and 0.95 (95% confidence interval: 0.52 to 0.99), respectively. In volunteers, the ECV was associated with age (r = 0.74, p < 0.001), maximal left atrial volume index (r = 0.67, p < 0.001), and indexed left ventricular mass. There were no differences in the ECV between segments in a slice or between slices. In mice (N = 12), the myocardial ECV ranged from 0.20 to 0.32 and increased with age (0.22 ± 0.02 vs. 0.30 ± 0.02, juvenile vs. aged mice, p < 0.001). In mice, the ECV correlated with the extent of myocardial fibrosis (r = 0.94, p < 0.001).
CONCLUSIONS: In healthy volunteers, the myocardial ECV ranges from 0.23 to 0.33, has acceptable test characteristics, and is associated with age, left atrial volume, and left ventricular mass. In mice, the ECV also increases with age and strongly correlates with the extent of myocardial fibrosis.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643283      PMCID: PMC3683385          DOI: 10.1016/j.jcmg.2012.09.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  40 in total

1.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

2.  Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia.

Authors:  Afshin Farzaneh-Far; Vignendra Ariyarajah; Chetan Shenoy; Jean-Francois Dorval; Matthew Kaminski; Zelmira Curillova; Henry Wu; Kenneth B Brown; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2011-04

3.  Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho; Begoña López; Otavio R Coelho-Filho; Neal K Lakdawala; Allison L Cirino; Petr Jarolim; Raymond Kwong; Arantxa González; Steven D Colan; J G Seidman; Javier Díez; Christine E Seidman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

4.  Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.

Authors:  Andrew S Flett; Jonathan Hasleton; Christopher Cook; Derek Hausenloy; Giovanni Quarta; Cono Ariti; Vivek Muthurangu; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2011-02

Review 5.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

Authors:  Nathan Mewton; Chia Ying Liu; Pierre Croisille; David Bluemke; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

6.  Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease.

Authors:  Clerio F Azevedo; Marcelo Nigri; Maria L Higuchi; Pablo M Pomerantzeff; Guilherme S Spina; Roney O Sampaio; Flávio Tarasoutchi; Max Grinberg; Carlos Eduardo Rochitte
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

7.  Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis.

Authors:  Marc R Dweck; Sanjiv Joshi; Timothy Murigu; Francisco Alpendurada; Andrew Jabbour; Giovanni Melina; Winston Banya; Ankur Gulati; Isabelle Roussin; Sadaf Raza; Nishant A Prasad; Rick Wage; Cesare Quarto; Emiliano Angeloni; Simone Refice; Mary Sheppard; Stuart A Cook; Philip J Kilner; Dudley J Pennell; David E Newby; Raad H Mohiaddin; John Pepper; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

8.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.

Authors:  Erik B Schelbert; Stephen M Testa; Christopher G Meier; William J Ceyrolles; Joshua E Levenson; Alexander J Blair; Peter Kellman; Bobby L Jones; Daniel R Ludwig; David Schwartzman; Sanjeev G Shroff; Timothy C Wong
Journal:  J Cardiovasc Magn Reson       Date:  2011-03-04       Impact factor: 5.364

9.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

10.  Myocardial T1 and extracellular volume fraction mapping at 3 tesla.

Authors:  Jason J Lee; Songtao Liu; Marcelo S Nacif; Martin Ugander; Jing Han; Nadine Kawel; Christopher T Sibley; Peter Kellman; Andrew E Arai; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-28       Impact factor: 5.364

View more
  46 in total

1.  Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.

Authors:  Otavio Rizzi Coelho-Filho; Ravi Shah; Carlos Fernando Ramos Lavagnoli; Jose Carlos Barros; Tomas G Neilan; Venkatesh L Murthy; Pedro Paulo Martins de Oliveira; Jose Roberto Matos Souza; Elaine Soraya Barbosa de Oliveira Severino; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira Filho; Jose Garcia; Marc J Semigran; Otavio Rizzi Coelho; Michael Jerosch-Herold; Orlando Petrucci
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-20       Impact factor: 2.357

2.  Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.

Authors:  Pascale Beliveau; Farida Cheriet; Stasia A Anderson; Joni L Taylor; Andrew E Arai; Li-Yueh Hsu
Journal:  Comput Biol Med       Date:  2015-08-08       Impact factor: 4.589

Review 3.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

4.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

5.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

6.  Right Ventricular Fibrosis Is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Matthew Jankowich; Siddique A Abbasi; Alexander Vang; Gaurav Choudhary
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

7.  Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.

Authors:  Hoshang Farhad; Pedro V Staziaki; Daniel Addison; Otavio R Coelho-Filho; Ravi V Shah; Richard N Mitchell; Balint Szilveszter; Siddique A Abbasi; Raymond Y Kwong; Marielle Scherrer-Crosbie; Udo Hoffmann; Michael Jerosch-Herold; Tomas G Neilan
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

8.  Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.

Authors:  Thiago Ferreira de Souza; Thiago Quinaglia A C Silva; Felipe Osorio Costa; Ravi Shah; Tomas G Neilan; Lício Velloso; Wilson Nadruz; Fabricio Brenelli; Andrei Carvalho Sposito; Jose Roberto Matos-Souza; Fernando Cendes; Otávio Rizzi Coelho; Michael Jerosch-Herold; Otavio Rizzi Coelho-Filho
Journal:  JACC Cardiovasc Imaging       Date:  2018-08

9.  Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.

Authors:  Stefan Neubauer; Paul Kolm; Carolyn Y Ho; Raymond Y Kwong; Milind Y Desai; Sarahfaye F Dolman; Evan Appelbaum; Patrice Desvigne-Nickens; John P DiMarco; Matthias G Friedrich; Nancy Geller; Andrew R Harper; Petr Jarolim; Michael Jerosch-Herold; Dong-Yun Kim; Martin S Maron; Jeanette Schulz-Menger; Stefan K Piechnik; Kate Thomson; Cheng Zhang; Hugh Watkins; William S Weintraub; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2019-11-12       Impact factor: 24.094

10.  Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.

Authors:  Tomas G Neilan; Francois-Pierre Mongeon; Ravi V Shah; Otavio Coelho-Filho; Siddique A Abbasi; John A Dodson; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.